Back to
AE Wealth Management LLC
XERS
Showing 0 of 7 quarters
Position history for
AE Wealth Management LLC's holdings in XERIS PHARMACEUTICALS INC
No. AE Wealth Management exited its XERS (Xeris Pharmaceuticals) position in Q2 2022. Its Q1 2022 13F listed 70,024 shares worth $179,000. AE Wealth Management first reported XERS in Q3 2020 and held it in 4 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.